SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

 

For the month of: June 2014		Commission File Number: 001-33526

 

 

NEPTUNE TECHNOLOGIES & BIORESSOURCES INC.

(Translation of Registrant’s name into English)

 

 

225 Promende du Centropolis

Suite 200

Laval, Québec

Canada H7T 0B3

(Address of Principal Executive Office)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  ¨            Form 40-F  x

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ¨

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes  ¨            No   x

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): N/A

 

 

 

On May 30, 2014 Neptune Technologies & Bioressources Inc. issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

				NEPTUNE TECHNOLOGIES & BIORESSOURCES INC.
Date: June 2, 2014				By:		/s/ André Godin
						Name: André Godin
						Title: Chief Financial Officer

---

EXHIBIT INDEX

 

Exhibit		Description of Exhibit
99.1		Press release dated May 30, 2014